Skyrizi fda approval date?

When was Skyrizi first approved by the FDA?

Skyrizi (risankizumab) received its initial FDA approval on April 14, 2017. [1]

Has Skyrizi been approved for other conditions since then?

Yes. After the 2017 approval for plaque psoriasis, Skyrizi later gained additional FDA indications as the label expanded to other uses. [1]

Source

1. https://www.drugs.com/history/risankizumab.html